Nurix Therapeutics Inc at Robert W Baird Global Healthcare Conference Transcript
Joining our next session with Nurix Therapeutics, I'm really pleased to have with us Arthur Sands, who is President and CEO of Nurix. To begin, Arthur has some prepared slides, and then we'll jump into some Q&A afterwards. Arthur, thanks for joining us.
Thank you, sure. Thank you very much. So Nurix is a leader in Targeted Protein Modulation. We developed small molecules that can modulate protein levels. Of course, I'll be making certain forward-looking statements. Refer to our filings with the SEC.
So what do we mean by Targeted Protein Modulation, as pictured here? So at all -- the center of our system is the E3 ligase enzyme system, which is pictured at the center of the slide. And this is a class of enzymes within the cell. There's over 600 of them encoded in the human genome. And they all have very specific functions.
And what they do is they ligate on a ubiquitin moiety -- which is pictured here in green, that little green peptide -- onto
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |